In the preimplantation mouse embryo, TEAD4 is critical to establishing the trophectoderm (TE)-specific transcriptional program and segregating TE from the inner cell mass (ICM). However, TEAD4 is expressed in the TE and the ICM. Thus, differential function of TEAD4 rather than expression itself regulates specification of the first two cell lineages. We used ChIP sequencing to define genomewide TEAD4 target genes and asked how transcription of TEAD4 target genes is specifically maintained in the TE. Our analyses revealed an evolutionarily conserved mechanism, in which lack of nuclear localization of TEAD4 impairs the TE-specific transcriptional program in inner blastomeres, thereby allowing their maturation toward the ICM lineage. Restoration of TEAD4 nuclear localization maintains the TE-specific transcriptional program in the inner blastomeres and prevents segregation of the TE and ICM lineages and blastocyst formation. We propose that altered subcellular localization of TEAD4 in blastomeres dictates first mammalian cell fate specification.
In the preimplantation mouse embryo, TEAD4 is critical to establishing the trophectoderm (TE)-specific transcriptional program and segregating TE from the inner cell mass (ICM). However, TEAD4 is expressed in the TE and the ICM. Thus, differential function of TEAD4 rather than expression itself regulates specification of the first two cell lineages. We used ChIP sequencing to define genomewide TEAD4 target genes and asked how transcription of TEAD4 target genes is specifically maintained in the TE. Our analyses revealed an evolutionarily conserved mechanism, in which lack of nuclear localization of TEAD4 impairs the TE-specific transcriptional program in inner blastomeres, thereby allowing their maturation toward the ICM lineage. Restoration of TEAD4 nuclear localization maintains the TE-specific transcriptional program in the inner blastomeres and prevents segregation of the TE and ICM lineages and blastocyst formation. We propose that altered subcellular localization of TEAD4 in blastomeres dictates first mammalian cell fate specification.
A llocation of blastomeres to outside and inside positions during preimplantation mammalian development initiates specification of the first two cell lineages, the trophectoderm (TE) and the inner cell mass (ICM) (1, 2) . Successful progression of TE and ICM fate specification and proper development of the preimplantation embryo depends on differential transcriptional programs that are instigated and maintained within the outer and inner cells. Gene-KO studies in mice showed TEAD4 as the master orchestrator of the TE-specific transcriptional program (3) (4) (5) . TEAD4-null embryos do not mature to the blastocyst stage and TEAD4-null blastomeres lack expression of TE-specific master regulators like CDX2, GATA3, and EOMES (3, 4) . However, they maintain expression of ICM-specific factors like OCT4 and NANOG.
Interestingly, TEAD4 expression is maintained both in cells of TE and ICM lineages, as well as in the TE-derived trophoblast stem cells (TSCs) and ICM-derived ES cells (ESCs) (5, 6) . Thus, questions are raised as to how TEAD4 selectively orchestrates the TE/TSC-specific transcriptional program but not the ICM/ ESC-specific transcriptional program. The current model predicts that the presence vs. the absence of a TEAD4 cofactor, yesassociated protein (YAP), modulates TEAD4 function at its target genes in outer vs. inner blastomeres (6) , leading to the segregation of the TE and ICM lineages. However, YAP-null mouse embryos do not show preimplantation developmental defects (7) , indicating that, unlike TEAD4, YAP function is dispensable during TE and ICM fate determination. It is proposed that another YAP-related cofactor, WWTR1 (i.e., TAZ), could compensate for the absence of YAP during early development (6) . However, the mode of TAZ function during TE and ICM specification is unknown. Furthermore, direct targets of TEAD4 have not been identified in the TE or in trophoblast cells. Thus, definitive experiments have not been performed to conclude that loss of cofactor function/recruitment is the crucial mechanism to impair transcription of TEAD4 target genes in the ICM. Therefore, in this study, we used a ChIP sequencing (ChIP-seq) analysis to determine TEAD4 target genes in mouse TSCs (mTSCs), validated those targets in the early mouse embryos, and asked how TEAD4-target genes are differentially regulated in inner vs. outer blastomeres during preimplantation development. Our analyses revealed an evolutionarily conserved mechanism, in which altered subcellular localization of TEAD4 orchestrates differential transcriptional program in outer vs. inner blastomeres and determines the first cell fate decision during preimplantation mammalian development.
Results
Identifying Direct Targets of TEAD4 in mTSCs. We conducted ChIP-seq in mTSCs to identify genomewide targets for TEAD4. Immunoprecipitated chromatin fragments were used to prepare libraries for deep sequencing, and sequences were mapped to the University of California, Santa Cruz, mouse genome assembly. Two control libraries were also generated and sequenced: one from total chromatin fragments before immunoprecipitation and the other from immunoprecipitated chromatin fragments using a nonspecific antibody (mouse IgG). These sequenced libraries were analyzed to detect TEAD4 ChIP peaks (SI Appendix, Fig.  S1 ), and specific targets of TEAD4 were identified by using a model-based analysis for ChIP-seq (Model-based Analysis of ChIP-Seq) algorithm (8) . By using a very high significance value (1 × 10
) for binding sites, we identified 4,949 TEAD4 binding regions (Dataset S1). We used the overrepresented motif detection algorithm Hypergeometric Optimization of Motif Enrichment (HOMER), which ranks motifs on the basis of their statistical enrichment (9) , to identify motifs localized within TEAD4 binding regions. HOMER analysis showed that the TEAD motif is the most prevalent motif at the identified binding regions, with a P value of 1 × 10 −89 (Fig. 1A) . Interestingly, TEAD4 binding regions are also enriched with binding motifs of other TSC-specific transcription factors (Fig. 1A) , like TCFAP2c, SOX2, JUNB, EOMES, and CDX2 (10) (11) (12) (13) (14) .
Through comparative gene expression analyses, the Ralston et al. (4) defined 1,928 core mTSC-specific genes, of which 1,552 corresponded to mouse RefSeq transcripts. Among those 1,552 genes, ChIP-seq detected TEAD4 binding peaks within ±50 kb of 321 genes ( Fig. 1B and Dataset S2), indicating that these might be the direct targets of TEAD4 in mTSCs. To validate genomewide analysis, we tested TEAD4 occupancy by conventional, real-time PCR-based quantitative ChIP (15) analysis at a subset of binding regions that are detected by ChIP-seq analysis. We selected 17 binding regions (Fig. 1C ) near or within genes, which have mTSC-specific expression patterns (4) and have been implicated in trophoblast biology or in normal development (4, 16) . The conventional quantitative ChIP analyses detected TEAD4 occupancy in 16 of those 17 regions, including a site at the 5′UTR of its own locus (Fig. 1C) . We also tested functional importance of TEAD4 in maintaining expression of these putative target genes in mTSCs. We specifically depleted TEAD4 expression in mTSCs by RNAi (SI Appendix, Fig. S2 A and B), and loss of TEAD4 resulted in strong transcriptional repression of TEAD4 target genes (SI Appendix, Fig. S2C ).
In preimplantation mouse embryos, TEAD4 is essential for the expression of GATA3 and CDX2 (3, 4) . RNAi analysis showed that maintenance of GATA3 and CDX2 expression in mTSCs is also TEAD4-dependent (SI Appendix, Fig. S2 D and E). However, our initial analysis of ChIP-seq data did not identify any TEAD4 binding region within the Cdx2 locus, and a binding site was detected at a nonconserved (+)36.3 kb region of the mouse Gata3 locus. Therefore, we hypothesized that we might have obtained false-negative results for some TEAD4-binding regions at the Gata3 and Cdx2 loci as a result of the stringency of our ChIP-seq analysis. Therefore, we analyzed Gata3 and Cdx2 loci for the presence of conserved TEAD (GGAATG) motifs. Our analyses revealed the presence of multiple conserved TEAD motifs within ±15 kb of the transcription start sites of mouse Cdx2 and Gata3 loci (SI Appendix, Fig. S3A ). Interestingly, when we compared TEAD4 ChIP-seq data with the Model-based Analysis of ChIP-Seq algorithm using only IgG ChIP-seq data set as control, we detected TEAD4-binding peaks at the Cdx2 intron 1, Cdx2 (+)6.5 kb, and Gata3 5′ UTR regions (SI Appendix, Fig. S3B ). To definitively conclude that TEAD4 occupies those regions of Cdx2 and Gata3 loci in mTSCs, we performed quantitative ChIP with mTSCs and detected TEAD4 occupancy at the conserved TEAD motifs within the intron 1 and 3′UTR regions of the Cdx2 locus and at the 5′UTR region of the Gata3 locus (Fig. 1D ).
Next, we tested TEAD4 occupancy at the chromatin domains of mTSC-specific genes in mouse blastocysts. To test TEAD4 chromatin occupancy in blastocysts, we combined ChIP analyses with whole-genome amplification (15) and detected TEAD4 occupancy at all mTSC-specific gene loci, including Cdx2 and Gata3 (Fig. 1E) . Collectively, the ChIP-seq and quantitative ChIP analyses showed that TEAD4 directly regulates transcription of key TE-specific regulators including Gata3 and Cdx2 in both mTSCs and preimplantation mouse embryos.
Lack of TEAD4 Nuclear Localization Impairs Its Target Gene Activation in ESCs. Although TEAD4 is expressed in the TE and the ICM, TEAD4 target genes such as Cdx2 and Gata3 are not expressed in the mouse ICM or ICM-derived mESCs, indicating that TEAD4-dependent transcriptional activation of these genes is impaired in those contexts. However, it has not been tested whether TEAD4 actually occupies the target chromatins in mESCs. We therefore tested TEAD4 expression and chromatin occupancy at its target genes in mESCs. Expression analyses revealed that, although in low quantity compared with mTSCs, TEAD4 mRNA and proteins are expressed in mESCs ( Fig. 2 A  and B) . However, ChIP analyses revealed that TEAD4 chromatin occupancy at its target loci is severely impaired in mESCs (Fig. 2C) . We asked whether the lack of TEAD4 chromatin occupancy is a result of the failure of TEAD4 to accumulate in mESCs nuclei. We performed immunofluorescence analysis to define the subcellular localization of TEAD4 and found that TEAD4 is localized only in the cytoplasm of mESCs (Fig. 2D , Upper). However, in mTSCs, TEAD4 is present in the cytoplasm and in nuclei, with more abundance in nuclei (Fig. 2D, Lower) . We also looked at the localization of YAP, and found that, unlike TEAD4, YAP is mostly concentrated in the nuclei of both mESCs and mTSCs. These results strongly indicate that, although TEAD4 is expressed in mESCs and mTSCs, nuclear localization of TEAD4 and therefore activation of its target genes is impaired in mESCs.
Next, we tested whether TEAD4 nuclear localization is altered in human ESCs (hESCs). As BMP4 treatment robustly induces trophoblast fate in hESCs (17, 18) , we treated H9 hESCs with BMP4 and assessed TEAD4 nuclear localization and its target gene, GATA3, expression. In hESCs, GATA3 is strongly induced upon BMP4 treatment, and TEAD4 mRNA and protein are abundantly expressed in undifferentiated and BMP4-treated Fig. S4A ). However, immunofluorescence studies revealed that undifferentiated hESCs lack TEAD4 protein in their nuclei (SI Appendix, Fig. S4B ), and, upon BMP4 treatement, TEAD4 nuclear localization precedes GATA3 expression (Fig. 2E) . Interestingly, unlike TEAD4, YAP nuclear localization is detected in BMP4-treated and untreated hESCs (SI Appendix, Fig. S4B ). We also performed quantitative ChIP analysis to determine TEAD4 chromatin occupancy at the GATA3 chromatin domain in hESCs. In correlation with the subcellular localization pattern, TEAD4 occupancy at the GATA3 chromatin domain was detected only in the BMP4-treated cells (SI Appendix, Fig. S4C ). Collectively, these results showed that BMP4 treatment induces TEAD4 nuclear localization in hESCs, activates its target genes like GATA3, and could contribute toward induction of trophoblast fate.
Impaired Nuclear Localization of TEAD4 Represses TE-Specific Genes in Nascent ICM. As TEAD4 protein was absent in nuclei of ICMderived mESCs, we tested subcellular localization pattern of TEAD4 in preimplantation mouse embryos. Immunofluorescence analyses of preimplantation mouse embryos showed strong TEAD4 nuclear localization in all the blastomeres of four-and eight-cell embryos ( Fig. 3A and SI Appendix, Fig. S5 ). However, in compacted morula-stage embryos, TEAD4 nuclear localization was observed only in the outer cells ( Fig. 3A and SI Appendix, Fig.  S5 ). Similarly, at the blastocyst stage, TEAD4 protein was detected only in the cytosol of the ICM lineage cells (Fig. 3A and SI Appendix, Fig. S5 ). By using two widely used, specific antibodies (SI Appendix, SI Experimental Procedures), we also tested YAP localization in mouse morula/blastocysts. Surprisingly, in contrast to earlier reports (6, 19) , we detected YAP proteins only within the nuclei of ICM lineage cells (SI Appendix, Fig. S6A ). Analyses of Yap −/− embryos confirmed specificity of anti-YAP antibodies (SI Appendix, Fig. S6B ).
Next, we tested whether TEAD4 chromatin occupancy at its target loci is impaired within the nascent ICM lineage of developing mouse embryos. For this study, we took embryos at the early blastocyst stage and isolated inner ICM lineage cells by immunosurgery (15) . With isolated inner cells, we performed ChIP/whole-genome amplification to test TEAD4 chromatin occupancy. We detected significant loss of TEAD4 chromatin occupancy at its target genes within the inner cells compared with that in the whole embryos (Fig. 3B) , and this loss of chromatin occupancy was associated with significant loss in mRNA expression of TEAD4 target genes, including Tead4 itself (Fig. 3C) . These results strongly indicate that the absence of TEAD4 protein Preimplantation mouse embryos at different developmental stages were analyzed by confocal microscopy for TEAD4 (red) and CDX2 (green) expression with respect to nuclei (blue). Three-dimensional projections of confocal images at morula-stage embryos demonstrate lack of TEAD4 nuclear localization and CDX2 expression in the inner cells (white border). The white arrows show a dividing cell. Bottom: Micrographs show confocal images of blastocysts with near-complete exclusion of TEAD4 and loss of CDX2 expression in the nuclei of the ICM (white borders). Quantitative ChIP (B) and RT-PCR (C) analyses show decreased TEAD4 chromatin occupancy at its target loci, and repression of TEAD4 target genes in the inner cells of late morula/early blastocyst-stage mouse embryos compared with whole embryos (mean ± SE; n = 3). Note high levels of Oct4 and Nanog mRNA expression in the inner cells.
in the nuclei of inner cells impairs TEAD4 chromatin occupancy resulting in decreased transcription of Tead4 itself and other target genes.
Restricted TEAD4 Nuclear Localization in TE Lineage Is a Conserved
Phenomenon. We tested whether restricted nuclear localization of TEAD4 to TE lineages is a conserved phenomenon in other mammalian species. Therefore, we investigated TEAD4 localization in blastocysts from rats, cattle, rhesus monkeys, and humans. Immunofluorescence studies revealed that, similar to the mouse, ICM nuclei of these species also lack TEAD4 protein (Fig. 4) . Thus, restricted nuclear localization of TEAD4 to the TE lineages is a conserved phenomenon during preimplantation development in other mammalian species, including human.
Induced TEAD4 Nuclear Localization in Inner Cells of Preimplantation
Embryos Prevents Segregation of TE and ICM Lineages. Analyses of mRNA expression revealed that TEAD4 expression is repressed in mESCs ( Fig. 2A) as well as in the ICM lineage cells (Fig. 3C) . Interestingly, in mESCs and in ICM lineage, loss of TEAD4 transcription is associated with loss of TEAD4 occupancy at the 5′UTR region of its own locus (Figs. 2C and 3B). Based on these observations, we hypothesized that TEAD4 positively autoregulates its own transcription in mTSCs and in the cells of TE lineage. However, impaired nuclear localization of TEAD4 disrupts the positive autoregulation in the ICM lineage and in mESCs, resulting in reduced TEAD4 protein levels compared with that in mTSCs (Fig. 2B ). We also hypothesized that reduced protein level facilitates cytosolic retention of TEAD4 in the mESCs and in the mouse ICM lineage. This hypothesis is supported by an earlier observation that overexpression of a TEAD4 construct induces trophoblast fate in mESCs (6) . Therefore, in the next set of experiments, we assessed positive autoregulation of TEAD4 and tested whether ectopic induction of TEAD4 induces its nuclear localization in mESCs and in the ICM lineage.
To test positive autoregulation, we assessed functional importance of conserved TEAD motifs at the TEAD4 5′UTR in transient transfection assays. We fused mouse TEAD4 promoter along with the 5′UTR region in front of a luciferase reporter gene (SI Appendix, Fig. S7A ). The TEAD4 5′UTR region contains two adjacent putative TEAD motifs (SI Appendix, Fig.  S7A ). We found that deletion of those adjacent TEAD motifs significantly reduced the expression of luciferase gene from the reporter construct in mTSCs (SI Appendix, Fig. S7A , Right).
These data strongly implicate those conserved TEAD motifs in enhancing transcription through TEAD4 promoter region in mTSCs, supporting a positive autoregulation.
To determine whether increased TEAD4 protein levels induce its nuclear localization, we generated a TEAD4-inducible mESC line (iTEAD4 cell), in which TEAD4 can be conditionally overexpressed in a tetracycline-inducible fashion. We efficiently induced TEAD4 protein expression in multiple clones of iTEAD4 cells (SI Appendix, Fig. S7B ) with doxycycline and evaluated its nuclear localization and chromatin occupancy. We found that ectopic overexpression resulted in TEAD4 nuclear localization (SI Appendix, Fig. S7C ) and chromatin occupancy at the target genes (SI Appendix, Fig. S7D ).
We next determined whether ectopic expression of TEAD4 induces its nuclear localization, thereby inducing expression of its target TE-specific genes in the inner blastomeres of a developing mouse embryo. We ectopically expressed TEAD4 in blastomeres by using a lentiviral construct. The TEAD4-expressing construct also expressed an EGFP protein that was linked with TEAD4 gene with a T2A linker (Fig. 5A) . Thus, ectopic expression of TEAD4 in developing embryos was monitored by EGFP expression (Fig. 5B) . We injected lentiviral particles at the one-cellstage embryos to induce TEAD4 expression and tested their development ex vivo. We found that ectopic expression of TEAD4 induced its nuclear localization and activated CDX2 expression in the inner blastomeres ( Fig. 5C ) and strongly inhibited morula to blastocyst transition of developing embryos (Fig. 5D) .
Next, we sought to examine whether induction of TEAD4 nuclear localization at physiological concentration affects transcriptional program in the inner blastomeres of a developing embryo. To that end, we focused on BMP4 signaling. BMP4 treatment could induce trophoblast fate in ESCs from different mammalian species like mouse, rabbit, and human (17, 20, 21) . Furthermore, we showed that BMP4 treatment induces TEAD4 nuclear localization in hESCs (Fig. 2E) . Thus, we asked whether enhanced BMP4 signaling induces TEAD4 nuclear localization in the inner cells of a developing mouse embryo. We exposed mouse embryos to BMP4 at different developmental stages. We found a strong delay in blastocyst formation when BMP4 treatment was initiated at the one-to eight-cell stage of a mouse embryo (Fig.  5 E and F) . Furthermore, immunofluorescence analyses in BMP4-treated embryos revealed that the inhibition in development is associated with induced TEAD4 localization and CDX2 expression in the nuclei of inner cells (Fig. 5G and SI Appendix, Figs. S8 and S9). Thus, we concluded that induction of TEAD4 nuclear localization in all blastomeres of an early preimplantation embryo inhibits its development to the blastocyst stage.
Interestingly, when BMP4 treatment was initiated at the late morula stage, no significant inhibitory effect was observed on blastocyst formation (Fig. 5F ). We hypothesized that lack of accessibility of BMP4 to the inner cells of a morula-stage embryo could be the reason behind this observation. Therefore, we injected BMP4 into the blastocoel cavities of early-stage mouse blastocysts (SI Appendix, Fig. S10 ). We found that exposure to BMP4 at that stage did not inhibit blastocyst expansion. However, TEAD4 nuclear localization and CDX2 expression was induced in the ICM lineage cells (Fig. 5 H and I) . These results further confirm that absence of nuclear TEAD4 protein is important to suppress TE-specific transcriptional program in the ICM-lineage cells.
Discussion
The inside-outside model (22) and the polarity model (23) propose that, in preimplantation embryos, inner blastomeres are functionally different from outer blastomeres. However, molecular mechanisms that specify and maintain differential transcriptional programs in outer vs. inner cells remain largely unknown. In this study, we demonstrated that transcription of several key TE-specific genes, as well as Tead4 itself, is directly regulated by TEAD4. However, transcription of those genes is impaired in the nascent ICM lineage because of the absence of nuclear TEAD4. We showed that differential subcellular localization of TEAD4 between TE and ICM lineages is a conserved event in several mammalian species, including human. We also showed that ectopic expression of TEAD4 induces its nuclear localization in the inner blastomeres, induces TE-specific genes, and prevents proper preimplantation development. Taken together, our results suggest a model (Fig. 6 ) in which reduced TEAD4 expression caused by disruption of a positive autoregulatory loop contributes to impaired TEAD4 nuclear localization in the inner blastomeres, thereby suppressing a TEspecific transcriptional program. We also propose that altered nuclear localization of TEAD4 is a conserved mechanism responsible for regulating distinct transcriptional programs in the nascent TE vs. ICM lineages, thereby allowing their specification and maturation of a preimplantation mammalian embryo to the blastocyst stage. A recent study in the context of endothelial cells showed that altered nuclear localization regulates TEAD4 function (24) . However, our findings regarding the exclusion of TEAD4 from the nuclei of the ICM lineage cells is different from an earlier report by Nishioka et al. (5) . That report indicated that, at the . TEAD4 mediated specification of TE and ICM lineages in a preimplantation mammalian embryo. The model illustrates that nuclear localization of TEAD4 in the outer TE lineage induces TE-specific genes like Gata3. TEAD4 nuclear localization positively autoregulates its own transcription and increases TEAD4 protein levels in the TE lineage. The high TEAD4 concentration facilitates its nuclear localization. The dotted line denotes other putative mechanisms, not yet supported by experimental evidence, which could regulate TEAD4 nuclear localization in polar outer cells. The model also predicts that low TEAD4, as well as the absence of other putative mechanisms, impairs TEAD4 nuclear localization in the ICM lineage, thereby limiting TEAD4 transcription and abrogating expression of other TE-specific genes, such as Gata3.
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blastocyst stage of a mouse embryo, TEAD4 protein is detectable in all nuclei of TE and ICM. We propose that different reagents and experimental procedures are probable reasons for the discrepancies in our findings and those of Nishioka et al. (5) .
As we were unable to analyze TEAD4-null mice or TEAD4-null mESCs, we validated the specificity of the TEAD4 antibody that is used in our study by three different tests: (i) by showing that TEAD motif is the most predominant motif in genomewide TEAD4-binding regions identified by ChIP-seq analysis; (ii) by specifically knocking down TEAD4 in mTSCs; and (iii) by overexpressing the mouse Tead4 gene in iTEAD4 cells and in preimplantation mouse embryos. Our mechanistic analyses showed evidence that a positive autoregulatory mechanism of TEAD4 expression could be important for altered protein levels in TE vs. ICM lineage cells (Fig. 6 ), which in turn could contribute to altered subcellular localization of TEAD4 in these two cell lineages. However, the molecular mechanism that initiates impairment of TEAD4 nuclear localization in inner blastomeres remains to be identified. Although we have shown that exposure of developing embryos to BMP4 can induce TEAD4 localization in inner cells, the lack of preimplantation developmental defect in BMP4-null mice (25) indicates that BMP4-dependent mechanisms are not the sole regulator in altering subcellular localization of TEAD4 in developing embryos. We predict that lack of cell polarization and absence of signaling from apical surfaces in the inner cells also contributes toward loss of TEAD4 nuclear localization. Thus, defining signaling mechanisms that prevent nuclear localization of TEAD4 in inner cells is an important subject of further study. Interestingly, as the appropriate TEAD4 nuclear localization patterns are maintained in mESCs and mTSCs, these stem cell populations can be exploited for further mechanistic studies.
Finally, the present model predicts that, in the ICM lineage cells or in ICM-derived ESCs, TEAD4 function is impaired, as the coactivator YAP is excluded from the nuclei of those cells (6) . It has been indicated that phosphorylation of YAP by hippo signaling component, LATS2 kinase, restricts its nuclear localization in the ICM lineage cells as well as in the nuclei of ICMderived mESCs (6) . However, we found that YAP is mainly present in the nuclei of undifferentiated mESCs (Fig. 2D ). Our observation in mESCs supports two recent studies (26, 27) . These studies indicated that YAP is predominantly found in the nuclei of undifferentiated mESCs and is important for inducing expression of pluripotency regulators OCT3/4 and NANOG to maintain mESC self-renewal. We also analyzed numerous mouse blastocysts and detected YAP in the ICM nuclei in all of them (SI Appendix, Fig. S6 ). As mentioned earlier, we confirmed specificity of YAP antibodies by using Yap −/− mouse embryos (SI Appendix, Fig. S6 ). These observations and our findings of impaired TEAD4 nuclear localization in the ICM/mESCs indicate that further study is important to definitively conclude involvement of a Hippo-LATS2-YAP axis in limiting TEAD4 function in those contexts.
Materials and Methods
ChIP and ChIP-Seq Analyses. Quantitative ChIP analyses with cultured cells and preimplantation embryos were performed following published protocols (15, 28) and is described in SI Appendix, SI Experimental Procedures. For TEAD4 ChIP-seq in mTSCs, immunoprecipitated chromatin fragments from three independent experiments were pooled, and genomic libraries were sequenced in Illumina Genome Analyzer II and in Illumina HiSeq platforms to generate 35-bp single end reads. Detailed bioinformatic analysis is described in SI Appendix, SI Experimental Procedures.
Analyses of Mammalian Preimplantation Embryos.
Procedures for collecting and culturing embryos from mice, rats, cattle, and rhesus monkeys are described in SI Appendix, SI Experimental Procedures. The human preimplantation embryos were collected at Stanford University according to all institutional rules, a two-stage consent process (29) , and approval from institutional committees at Stanford University and the University of Kansas Medical Center. Fixed, discarded, and deidentified human blastocysts were analyzed for TEAD4 expression pattern by immunofluorescence study following protocols described in SI Appendix, SI Experimental Procedures. Additional experimental procedures are detailed in SI Appendix, SI Experimental Procedures. 
ACKNOWLEDGMENTS. We thank
Table S1
Describes Genome-wide TEAD4 binding regions, identified by ChIP-Seq analysis in mouse TS cells.
Table S2
Describes core mouse TS-cell-specific TEAD4 target genes. 
SI Experimental Procedures with References
Describes experimental procedures, details of bioinformatics analysis of ChiP-seq data and lists oligonucleotides and antibodies used for the study. 
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Quantitative RT-PCR
Total RNA from cells was extracted with TRIzol reagent (Invitrogen) and analyzed for qRT-PCR following procedures, described earlier (3, 4) . For expression analysis in preimplantation embryos, total RNA was isolated using PicoPure RNA isolation kit (MDS Analytical Technology, Sunnyvale, CA) and processed as described earlier (1). Oligonucleotudes, used for qRT-PCR analyses are described below.
Western blot analysis.
Western blot analysis was performed as mentioned earlier (1). Antibodies are described below.
ChIP and ChIP-Seq analyses
Quantitative ChIP analyses with cultured cells were performed following published protocols (1, 4, 5) .
For ChIP analysis with preimplantation embryos, ~200 embryos were subjected to immunosurgery, cross-linked with 1% formaldehyde, and ChIP analysis performed with recovered blastomeres S13 according to a protocol described earlier (1) . For ChIP analyses with first-trimester (8-9 weeks) human placental tissue, collected tissues were crosslinked with 1% formaldehyde for 15 min, homozenized, sonicated, and cross-linked chromatin fragments were immunoprecipitated with anti-TEAD4 antibody.
Primers used for quantitative ChIP analyses are described below.
For TEAD4 ChIP-seq in mTSCs, Immunoprecipitated chromatin fragments from three independent experiments were pooled and genomic libraries were sequenced in Illumina Genome
Analyzer II and in Illumina HiSeq platforms to generate 35 bp single end reads. Two control samples, input and IgG, were used to eliminate false positive peak calls of TEAD4 binding sites. Input control reads were comprised of sonicated reverse-cross-linked chromatin not subjected to any antibody treatment. IgG control reads were comprised of sonicated chromatin immunoprecipitated DNA using mouse IgG that does not specifically bind to any DNA binding protein. Detailed bioinformatic analysis is described below.
ChIP-seq data analysis
ChIP-seq samples were generated as described above from mTS cell-chromatin fragments by precipitating with anti-TEAD4 antibody. Libraries were sequenced in Illumina Genome Analyzer II using TruSeq SBS kit v5-GA chemistry and in Illumina HiSeq using TruSeq SBS v2-HS chemistry (Illumina, San Diego, CA) to generate 35 bp single-end reads. Sequence reads were extended insilico at their 3' end to 200 bps, approximating the average fragment length in the size-selected library.
Two different but standard control samples, input and IgG, were used to eliminate false positive peak calls of TEAD4 binding sites. Input control reads were comprised of sonicated reverse-cross-linked chromatin not subjected to any antibody treatment. IgG control reads were comprised of immunoprecipitated chromatin using IgG antibody that does not specifically bind to any DNA binding protein.
Sequences were aligned using ELANDv2 (CASAVA 1.7) to the mouse reference genome (NCBI37/mm9) using default parameters. Peak detection was performed using the Model-based S14 Analysis of ChIP-Seq (MACS) algorithm (6, 7). The TEAD4 ChIP-peak regions were further analyzed with Cis-Regulatory Element Annotation System (CEAS) (8) to determine chromosomal distribution ( Figure S1 ). Peak detection by MACS analysis was performed separately with Input and IgG-ChIP control samples using a peak detection p-value cutoff set at 1e-5 (default). The results were integrated by selecting only those ChIP regions that were significantly enriched over both Input and
IgG. This resulted in a set of 4959 TEAD4 binding sites highly enriched against both Input and IgG control samples.
We searched for the TEAD4 consensus sequence within a 250 bp region from either side of the called peaks using a weight-matrix match with at least 80% similarity. The TEAD1 weight matrix obtained from the JASPAR database (9) Figure 4G ).
Collection and culture of preimplantation embryos
All procedures were performed after obtaining IACUC approvals at University of Kansas after treatment with hyaluronidase (300 µg/ml M2, Sigma) and cultured in KSOM (Millipore) at 37 °C in a humidified chamber at 5% CO 2 . Preimplantation embryo developments were also evaluated following BMP4 treatment (100ng/ml) in KSOM until the blastocyst stage. Embryos were visualized daily, photographed, and sampled for immunostaining.
For observation of BMP4 induced TEAD4 nuclear localization in the ICM lineage cells, BMP4
(200 ng/ ml, ~50 pl) was microinjected in the blastocoel of early mouse blastocysts (Fig. 5H) . The injection buffer (Millipore #MR-095-F) was used as vehicle control. Embryos were cultured in KSOM for another 6-8 hours and analyzed for TEAD4 nuclear localization and CDX2 expression.
Rat embryos: 6-week old female Dark Agouti rats (DA/OlaHsd strain, Harlan Laboratories)
were mated overnight to DA males (8 week old) and euthanized by cervical dislocation on day 4.5 post coitum. Uteri were collected after euthanasia and flushed with M2 medium (Millipore) for the collection of blastocysts.
Cattle embryos: Bovine oocytes from follicles 3-8 mm in size were aspirated into 50-ml centrifuge tubes using an 18-gauge needle attached to a vacuum pump. Oocytes with uniform cytoplasm and intact multiple layers of cumulus cells were selected and washed with PB1+ (PBS with Ca2+ and Mg2+ plus 5.55 mM glucose, 0.32 mM sodium pyruvate, 3 mg/ml BSA). Oocytes were transferred into 500 mL of maturation medium, M199, containing 10% fetal bovine serum (FBS;
Hyclone Laboratories, Logan, UT), 0.5 mg/ml FSH (Sioux Biochemicals, Sioux City, IA), 5 mg/ml LH (Sioux Biochemicals), 100 units/ml penicillin (Life Technologies, Grand Island, NY), and 100 mg/ml streptomycin (Life Technologies) in four-well culture dishes (Nunc, Milwaukee, WI) and cultured at 39 0 C in a humidified atmosphere of 5% CO 2 and air for 24 h. 24 h in vitro matured bovine oocytes were subjected to in vitro fertilization following a standardized protocol (13) for 18-20 h at 39 0 C in 5% CO2 and air. After fertilization, oocytes were vortexed for 2 min 40 sec in a 15-ml conical centrifuge tube containing 1 ml PB1+ medium to completely remove unbound sperm. Presumptive embryos were co-cultured on a monolayer of bovine cumulus cells in CR1aa medium containing 3% FBS at S17 39 0 C in 5% CO 2 and cleavage was determined 24 h after removal of sperm. Medium was changed every 2 days during the in vitro culture period until day 7 at which time blastocysts were placed into 4% paraformaldehyde in PBS in order to fix the embryos. were cultured to the blastocyst stage (7 days).
Human embryo:
The human preimplantation embryos were collected at the Stanford University according to all the institutional rules, a two-stage consent process (14) , and approval from institutional committees at both Stanford University and the University of Kansas Medical Center.
Fixed, discarded, and de-identified human blastocysts were analyzed for TEAD4 expression pattern by immunofluorescence study.
Ectopic expression of TEAD4 in a preimplantation mouse embryo:
Lentiviral vector pLKO.Tead4-T2A-EGFP (Fig. 5A ) was used to ectopically express TEAD4 in preimplantation mouse embryos. Lentiviral supernatants were collected 48 h post-transfection and viral particles were concentrated at 50,000g and resuspended in PBS. Lentiviral vector titers were determined by measurement of p24 gag antigen by ELISA (Advanced Bioscience Laboratories, Kensington, MD). 5X10 9 viral particles were used to microinject in the perivitelline space of zygotic mouse embryos. Injected embryos were incubated in KSOM in 5% CO 2 in a 37°C incubator. Embryos S18 were visualized and photographed every day and were subjected to immunostaining or immunosurgery followed by RT-PCR or ChIP analyses.
Immunostaining of preimplantation embryos:
For immunostaining, preimplantation embryos were fixed with 4% paraformaldehyde, permeabilized in 0.25% Triton X-100, and blocked with 10% fetal bovine serum and 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 1 h at room temperature. Embryos were incubated with antibodies (1:100 dilution) overnight at 4 °C, washed in 0.1% Triton X-100 in PBS. After incubation The Yap -/-embryos were recovered after immunostaining, washed with PBS, lysed in genomic lysis buffer (20mM Tris, pH 8.0, 100 mM KCl, 4 mM MgCl2, 0.9% Nonidet P40, 0.9% Triton X-100 and 300 ng/ml proteinsase K) followed by 1 hour heat inactivation of proteinase K at 98°C which also serves the purpose of reverse cross-linking. The lysate was used for genotyping using primers 5'-GAAGCTGTGGCACAAAGA-3' (forward), 5'-CGACGTTAACGGTACCAA-3' (mutant), 5'-ATGCAAAGGCCACACTGT-3' (wild type).
S19
Generation of mESC lines with Inducible TEAD4 expression system
Cre-mediated recombination was used to generate a mESC line with doxycycline inducible TEAD4 following procedures described previously (27) . In brief, a cDNA encoding mouse TEAD4 (Open Biosystems, Clone ID 40142595, GenBank: BC130257.1) was cloned into the engineered PALP targeting vector, and the resulting construct was co-electroporated with a Cre-expressing plasmid in Ainv15 cells (28) . After G418-selection, clones with appropriate recombination were confirmed via PCR genotyping, and tested for Dox-inducible expression.
Mouse Tead4 promoter/5'UTR cloning, TEAD motif mutation and reporter assay
Mouse Tead4 promoter region (-699 bp from transcription start site to +401 bp) was cloned into Mlu I/ Bgl II in pGL3 Basic luciferase reporter vector (Promega) to produce pGL3 -Tead4 promoter construct. For the deletion mutation, -699 bp to + 330 bp (two close TEAD binding motifs CTCATTCCAGCG and TGCATTCCTGCC, are located within +328 to +359bp) was cloned into Mlu I/ Xho I in pGL3 Basic to generate clone 1. Next +362 bp to +401 bp was cloned into Xho I/ Bgl II in clone 1 to generate pGL3-DTead construct in which the two successive TEAD binding motifs were deleted and were replaced by a Xho I restriction site. These constructs were used to transfect TS cells and transfected cells were used to measure luciferase activity as described previously (1).
Generation of TEAD4-T2A-GFP construct
To generate the TEAD4-T2A-GFP construct, oligos corresponding to the T2A sequence were annealed and cloned into BamH1/Kpn1 sites of the TOPO-TA vector (Invitrogen) to generate TOPO-T2A. PCR purified EGFP from pLKO.3G (Addgene #14748) was cloned into Kpn1/EcoR1 sites downstream of T2A. Tead4 cDNA was PCR amplified from a Tead4 cDNA clone (GenBank:
BC130257.1, Open Biosystems) and ligated into the BamH1/Sal1 of TOPO-T2A. Tead4-T2A-EGFP fragment was finally cloned into pLKO.3G in BamH1/EcoRV restriction sites to construct pLKO.Tead4-T2A-EGFP.
S20
Embryo immunosurgery
Immunosurgery of mouse morula/early blastocyst was performed according to the method described earlier (1) . Zonae pellucidae were removed from morula/early blastocysts using 0.5% Pronase (Sigma) for 5 min. The zona-free embryos were then treated with rabbit anti-mouse serum (Sigma) at 1:100 dilution for 30 min, washed with PBS, and incubated with guinea pig complement (Innovative Research, Novi, MI) at 37 °C in 5% CO 2 for 30 min. After washing, inner cells were collected for RNA preparation or ChIP analyses. mRNAs were isolated by the PicoPure RNA isolation kit, and subsequent RT-PCR analysis was performed as mentioned earlier (1) . 
Oligonucleotides used
